Z Z Pan
Overview
Explore the profile of Z Z Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang D, Huang S, Liao Y, Mi S, Zhou J, Feng Y, et al.
J Transl Med
. 2024 Aug;
22(1):742.
PMID: 39107788
Background: LARC patients commonly receive adjuvant therapy, however, hidden micrometastases still limit the improvement of OS. This study aims to investigate the impact of VASN in rectal cancer with pulmonary...
2.
Pan Z, Yu L, Peng J
Zhonghua Wei Chang Wai Ke Za Zhi
. 2022 Jun;
25(6):558-562.
PMID: 35754223
At present, comprehensive treatment dominated by surgical procedures is an important measure for colon cancer to obtain the chance of cure. Surgical intervention, while removing the tumor, carries the risk...
3.
Zhang W, Zhou C, Deng Y, Hou Z, Zhang L, Lin J, et al.
Zhonghua Wei Chang Wai Ke Za Zhi
. 2022 Jan;
25(1):56-62.
PMID: 35067035
To investigate the factors affecting the success of conversion therapy in patients with initially unresectable colorectal cancer liver metastases (CRLM) in order to provide evidence-based medical evidence for formulating individualized...
4.
Pan Z
Zhonghua Wei Chang Wai Ke Za Zhi
. 2021 Oct;
24(10):919-924.
PMID: 34674468
Liver metastasis is the leading cause of death in patients with colorectal cancer. Since surgical resection alone has a high postoperative recurrence rate, neoadjuvant therapy as an important means is...
5.
Wang X, Zhou C, Zhang S, Wang Q, Xiao W, Ding P, et al.
Zhonghua Wei Chang Wai Ke Za Zhi
. 2020 Mar;
23(3):266-273.
PMID: 32192306
To compare long-term efficacy between watch and wait (W&W) strategy and total mesorectal excision (TME) in patients who were diagnosed with locally advanced rectal cancer (LARC) and attained clinical complete...
6.
Wu X, Fu C, Chen Y, Kong L, Pan Z, Zheng M
Zhonghua Yi Xue Za Zhi
. 2019 Aug;
99(30):2337-2343.
PMID: 31434413
To explore the effect of biofeedback training combined with pelvic floor muscle exercise on the recovery of anorectal function in patients with middle and low rectal cancer undergoing sphincter-preserving surgery,...
7.
Pan Z, Song Y, Zhang Q, Yu J, Zhang K, Liang N, et al.
Zhonghua Yu Fang Yi Xue Za Zhi
. 2018 Sep;
52(9):946-950.
PMID: 30196644
To investigate the infection status and genotype distribution of cervical human papillomavirus (HPV) in women of different ethnic groups and different ages in Yili, Xinjiang Uygur Autonomous Region (Xinjiang). By...
8.
Xiao Z, Zhang R, Zhao Y, Peng J, Lu S, Zhang H, et al.
Zhonghua Yi Xue Za Zhi
. 2017 Apr;
97(16):1248-1251.
PMID: 28441855
To explore the expression of mismatch repair (MMR) proteins in sporadic colorectal cancer (SCRC) patients, and its association with clinicopathological characteristics of SCRC. Patients with histologically confirmed colorectal cancer were...
9.
Zhang R, Lu Z, Wan D, Wu X, Ding P, Kong L, et al.
Int J Colorectal Dis
. 2012 Jun;
27(12):1645-50.
PMID: 22664945
Background: Oxaliplatin is effective in adjuvant and first-line colorectal cancer chemotherapy. Oxaliplatin-induced severe chronic neurotoxicity is the main dose-limiting adverse event. No standard treatment for oxaliplatin-induced chronic neurotoxicity has been...
10.
Zhang R, Wu X, Wan D, Lu Z, Kong L, Pan Z, et al.
Ann Oncol
. 2011 Sep;
23(5):1348-1353.
PMID: 21940785
Background: Hand-foot syndrome (HFS) is the most common adverse event induced by capecitabine. Some clinicians think that HFS is a type of inflammation limited to the hands and feet and...